Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers

J J. Dale, C. V. Ruckley, D.R Harper, B. Gibson, EA Nelson, Robin J Prescott

Research output: Contribution to journalArticlepeer-review

Abstract

Objective
To determine whether pentoxifylline 400 mg (Trental 400) taken orally three times daily, in addition to ambulatory compression bandages and dressings, improves the healing rate of pure venous ulcers.
Design
Randomised, double blind placebo controlled trial, parallel group study of factorial design, permitting the simultaneous evaluation of alternative pharmaceutical, bandaging, and dressings materials.
Setting
Leg ulcer clinics of a teaching and a district general hospital in southern Scotland.
Participants
200 patients with confirmed venous ulcers and in whom other major causal factors were excluded.
Interventions
Pentoxifylline 400 mg three times daily or placebo.
Main outcome measure
Complete healing (full epithelialisation) of all ulcers on the trial leg.
Results
Complete healing occurred in 65 of the 101 (64%) patients receiving pentoxifylline and 52 of the 99 (53%) patients receiving placebo.
Conclusions
The difference in the healing rates between patients taking pentoxifylline and those taking placebo did not reach statistical significance.
Original languageEnglish
Pages (from-to)875-8
Number of pages4
JournalBritish Medical Journal (BMJ)
Volume319
Issue number7214
DOIs
Publication statusPublished - 2 Oct 1999

Keywords

  • sleep
  • death
  • LACTATION
  • PREGNANCY
  • Pathogenesis
  • leg ulcers
  • VENOUS ULCERS
  • Diabetes
  • venous disease
  • ulcer disease
  • gangrene

Fingerprint Dive into the research topics of 'Randomised, double blind placebo controlled trial of pentoxifylline in the treatment of venous leg ulcers'. Together they form a unique fingerprint.

Cite this